What is Bio Med Sciences?
Bio Med Sciences, established in 1987, is a prominent player in the biomedical field, specializing in the development of innovative skin products. Their product portfolio addresses critical needs in wound care, burn care, scar prevention and reduction, and skin firming. The company's proprietary Silon technology, a unique combination of silicone and Teflon properties, enables the creation of advanced solutions for both healthcare providers and consumers. Bio Med Sciences caters to a broad market, including individuals seeking cosmetic improvements for scars and wrinkles, healthcare professionals requiring effective treatment options, and manufacturers in need of sophisticated skin adhesive systems.
How much funding has Bio Med Sciences raised?
Bio Med Sciences has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Bio Med Sciences?
With the recent strategic investment, Bio Med Sciences is poised for accelerated growth and further innovation in its specialized biomedical product lines. The substantial capital infusion, characteristic of large-scale late-stage funding, suggests a strategic focus on expanding market reach, enhancing research and development for next-generation Silon technology applications, and potentially scaling manufacturing capabilities. This backing will likely enable the company to solidify its market leadership in advanced wound and scar management, driving further advancements in skin health solutions for a global clientele.
See full Bio Med Sciences company page
